[The problem of indexation of left ventricular myocardial mass by body size in obese patients]

Terapevticheskii Arkhiv
|November 2, 2006
PubMed

Insights

The Cornell product (Crn-P) electrocardiogram (ECG) criterion is most sensitive for detecting left ventricular myocardial hypertrophy (LVH) in hypertensive patients, regardless of body mass. Its effectiveness is influenced by body mass index and gender.

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Hypertension is a significant risk factor for cardiovascular diseases.
  • Left ventricular myocardial hypertrophy (LVH) is a common complication of hypertension.
  • Accurate detection of LVH is crucial for risk stratification and management.

Purpose of the Study:

  • To evaluate the diagnostic efficacy of various electrocardiogram (ECG) criteria for left ventricular myocardial hypertrophy (LVH).
  • To assess how body mass, including obesity, influences the sensitivity of these ECG criteria in hypertensive patients.

Main Methods:

  • Analysis of ECG data from 100 hypertensive patients (grades 1-2).
  • Assessment of LVH using Sokolov-Lion (S-L), Cornell voltage (Crn-V), and Cornell product (Crn-P) criteria.
  • Categorization of patients into normal weight, overweight, and obese groups based on body mass index.

Main Results:

  • The Cornell product (Crn-P) criterion demonstrated the highest sensitivity across all body mass groups.
  • The sensitivity of ECG criteria for LVH varied based on the specific criterion used, patient gender, and body mass index.
  • Indexation methods and excessive body mass significantly impacted the informative value of ECG criteria.

Conclusions:

  • The Cornell product (Crn-P) is a highly sensitive ECG criterion for LVH in hypertensive individuals, even with varying body mass.
  • The diagnostic accuracy of ECG criteria for LVH is modulated by the chosen indexation method and the degree of overweight or obesity.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...